LISA MOYERS: Open Payments
NPI 1881179190 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$823 in 32 payments from 7 companies in 2025. Trend: 2023 $1,332 · 2024 $1,258 · 2025 $823
Food & beverage: $823
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $375 |
| Incyte Corporation | 2 | $146 |
| Amgen Inc. | 5 | $124 |
| UCB, Inc. | 3 | $93 |
| Organon LLC | 3 | $37 |
| Regeneron Healthcare Solutions, Inc. | 1 | $30 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
Products named: RINVOQ, Opzelura, OTEZLA, SKYRIZI, Bimzelx, BOTOX, DUPIXENT, VTAMA.
Industry payments across TX — which companies pay providers there.
